Estonia's reputation for technological innovation extends beyond software to include high-precision medical manufacturing, as exemplified by Raumedic Estonia. Specializing in producing medical components with micrometer-level precision, Raumedic Estonia AS has become a key player in the medical manufacturing sector, contributing to Estonia’s growing influence in global healthcare technology.
As a subsidiary of the REHAU Group, Raumedic Estonia operates with a team of 80 employees and boasts over 1,350 m² of ISO Class 7 cleanroom facilities. The company produces a variety of essential medical components such as spirometry tubes, water traps, and gas sampling lines, all manufactured under strict cleanroom conditions.
Expanding Production and Estonia’s Role in Global Manufacturing
Raumedic Estonia’s roots trace back to its former identity as A&G, which was acquired by Raumedic in 2021. Following the acquisition, the company expanded its production capacity by constructing a new Class 7 cleanroom, designed for high-demand bioburden control. This new facility covers over 600 square meters, adding to the existing 5,000 square meters of production space. The company also has plans for future growth, potentially doubling cleanroom capacity as market demand increases.
Why Estonia for High-Precision Manufacturing?
Raumedic’s decision to expand in Estonia stems from its established relationship with A&G, which was already supplying Raumedic. Beyond that, Estonia’s strengths in high-precision manufacturing, a skilled workforce, and smart manufacturing expertise made it the ideal location for this expansion.
According to Emöke Sogenbits, Managing Director of Raumedic Estonia, "Estonia offers very good labor potential and a high-quality workforce, making it a great place for smart, precise manufacturing. Considering Estonia’s history in smart manufacturing, I believe this is an excellent location for our industry."
Future Expansion Plans
With over 5,000 square meters of production space and a cleanroom operating in two shifts, Raumedic Estonia has the capacity to significantly expand its manufacturing capabilities. Sogenbits noted that the company could potentially triple or quadruple production by adding more shifts and expanding its cleanroom facilities, depending on how quickly customers are ready to transition their products to Estonia.
Global Reach of Raumedic Estonia
While Raumedic Estonia’s main export markets are in Europe, its products reach a global audience through partnerships with large pharmaceutical companies. The company’s components are often shipped to Germany or the Netherlands but end up being used worldwide in the medical field.
The Future of Medical Manufacturing and Opportunities for Estonia
The global medical manufacturing industry is evolving, driven by an aging population and advancements in personalized medicine. Raumedic Estonia is well-positioned to capitalize on these trends, with its expertise in producing single-use medical components becoming increasingly valuable. However, the conservative nature of the healthcare sector means that innovations take time to implement, as regulatory approvals can stretch for years.
Estonia’s future in high-precision manufacturing is bright. The country excels in producing high-value, complex products that require precision and skill. Sogenbits emphasized that Estonia's strength lies in its ability to add value through labor, making it competitive in global markets. “With our brain power, language skills, and precision capabilities, we can truly stand out in the global market,” she added.
Raumedic’s success is a testament to Estonia’s potential as a hub for advanced manufacturing, particularly in healthcare, and highlights the country’s role in pushing the boundaries of what’s possible in medical technology.
Interested in Doing Business in Estonia?
If you’re considering investing or expanding in Estonia’s high-precision manufacturing sector, contact Invest Estonia for personalized 1:1 e-consulting and get started today.
